Delivery Order SPE2DR25D2101-SPE2DR26F45NU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, represents a non-set-aside competitive procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $16,000 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 28, 2025, with an ultimate completion date of October 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,173.74 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,306.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order executed under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,854.44 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) on October 23, 2025, with an ultimate completion date of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $24,465.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on September 19, 2025, with a completion date of September 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $5,192.16, with an ultimate completion date of September 2, 2025. This is a non-set-aside delivery order issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,296.32 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F45NUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,519.86 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive, firm fixed-price delivery order was awarded on November 7, 2025, with an ultimate completion date of November 10, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply support to military and federal healthcare systems. As a major pharmaceutical distributor and critical vendor within the federal medical procurement ecosystem, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX contract represents a comprehensive global pharmaceutical support vehicle enabling the company to furnish diverse pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This particular delivery order for Eliquis, an anticoagulant medication, exemplifies the routine medical supply chain transactions processed through this indefinite delivery vehicle to meet federal healthcare operational requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 11/7/25 |